Seroprevalence and risk factors of Kaposi's sarcoma-associated herpesvirus infection among the general Uygur population from south and north region of Xinjiang, China
- PMID: 22168313
- PMCID: PMC3266657
- DOI: 10.1186/1743-422X-8-539
Seroprevalence and risk factors of Kaposi's sarcoma-associated herpesvirus infection among the general Uygur population from south and north region of Xinjiang, China
Abstract
Background: Kaposi sarcoma (KS) is a complex multifocal neoplasm and is the major cause of death for about 50% of acquired immunodeficiency syndrome (AIDS) patients. Kaposi's sarcoma-associated herpesvirus (KSHV) is an oncogenic virus with a causal role in the development of all types of KS. KS is prevalent among the Uygur people in Xinjiang, especially in south area. Here we carried out a cross-sectional study among 1534 general Uygur individuals from south and north region of Xinjiang to assess the seroprevalence of KSHV and to identify the potential correlation between KSHV seroprevalence and KS incidence.
Results: Seroprevalence of KSHV in South and North Xinjiang was 23.1% and 25.9%, respectively. Older age was independently associated with higher KSHV seroprevalence. In subjects from South Xinjiang, lower educational level and reported drinking were each independently associated with higher KSHV seroprevalence. Furthermore, the antibody titer was significantly lower in both south and north KSHV seropositive individuals compared with KS patients, as analyzed by gradient dilution (P < 0.001).
Conclusion: KSHV is highly prevalent in the general Uygur population in both South and North Xinjiang. Interestingly, the infection rate of KSHV in these two geographical areas did not correlate well with KS incidence. Perhaps unknown factors exist that promote the progression of KSHV infection to KS development in the local minority groups.
© 2011 Wang et al; licensee BioMed Central Ltd.
Figures
Similar articles
-
Prevalence of Kaposi's sarcoma-associated herpesvirus in Uygur and Han populations from the Urumqi and Kashgar regions of Xinjiang, China.Virol Sin. 2017 Oct;32(5):396-403. doi: 10.1007/s12250-017-4049-9. Epub 2017 Oct 25. Virol Sin. 2017. PMID: 29116591 Free PMC article.
-
Seroprevalence of Kaposi's sarcoma-associated herpesvirus and risk factors in Xinjiang, China.J Med Virol. 2009 Aug;81(8):1422-31. doi: 10.1002/jmv.21550. J Med Virol. 2009. PMID: 19551832 Free PMC article.
-
Social behavioral correlates of Kaposi sarcoma-associated herpesvirus infection among Han and Uygur populations in Xinjiang, China.J Med Virol. 2019 Mar;91(3):457-462. doi: 10.1002/jmv.25332. Epub 2018 Oct 15. J Med Virol. 2019. PMID: 30281827
-
Seroepidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV).Semin Cancer Biol. 1999 Jun;9(3):175-85. doi: 10.1006/scbi.1998.0089. Semin Cancer Biol. 1999. PMID: 10343069 Review.
-
Kaposi's Sarcoma-Associated Herpesvirus: Epidemiology and Molecular Biology.Adv Exp Med Biol. 2017;1018:91-127. doi: 10.1007/978-981-10-5765-6_7. Adv Exp Med Biol. 2017. PMID: 29052134 Review.
Cited by
-
Seroprevalence of Kaposi's sarcoma-associated herpesvirus among HIV-infected Uygurs in Xinjiang, China.J Med Virol. 2017 Sep;89(9):1629-1635. doi: 10.1002/jmv.24804. Epub 2017 Apr 11. J Med Virol. 2017. PMID: 28252177 Free PMC article.
-
Epidemiology and transmission of Kaposi's sarcoma-associated herpesvirus.Viruses. 2014 Nov 4;6(11):4178-94. doi: 10.3390/v6114178. Viruses. 2014. PMID: 25375883 Free PMC article. Review.
-
Prevalence of Kaposi's sarcoma-associated herpesvirus in Uygur and Han populations from the Urumqi and Kashgar regions of Xinjiang, China.Virol Sin. 2017 Oct;32(5):396-403. doi: 10.1007/s12250-017-4049-9. Epub 2017 Oct 25. Virol Sin. 2017. PMID: 29116591 Free PMC article.
-
HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus.Clin Microbiol Rev. 2024 Sep 12;37(3):e0002223. doi: 10.1128/cmr.00022-23. Epub 2024 Jun 20. Clin Microbiol Rev. 2024. PMID: 38899877 Free PMC article. Review.
-
Is human herpesvirus 8 infection more common in men than in women? Systematic review and meta-analysis.Int J Cancer. 2016 Aug 15;139(4):776-83. doi: 10.1002/ijc.30129. Epub 2016 Apr 26. Int J Cancer. 2016. PMID: 27062038 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical